Association of lipoprotein lipase D9N polymorphism with myocardial infarction in type 2 diabetes The genetics, outcomes, and lipids in type 2 diabetes (GOLD) study

被引：19

作者：

Izar, Maria C. ^{[1
]}

Helfenstein, Tatiana ^{[1
]}

Ihara, Silvia S. ^{[1
]}

Relvas, Waldir G. ^{[1
]}

Santos, Andreza O. ^{[1
]}

Fischer, Simone C. ^{[1
]}

Pinto, Leonor E. ^{[1
]}

Lopes, Ieda E. ^{[1
]}

Pomaro, Daniel R. ^{[1
]}

Fonseca, Marilia I. ^{[1
]}

Bodanese, Luis C. ^{[1
]}

Moriguchi, Emilio H. ^{[1
]}

Saraiva, Jose F. ^{[1
]}

Introcaso, Luiz ^{[1
]}

Souza, Agnaldo D. ^{[1
]}

Scartezini, Marileia ^{[1
]}

Torres, Kerginaldo P. ^{[1
]}

Zagury, Leao ^{[1
]}

Jardim, Paulo C. ^{[1
]}

Costa, Eduardo A. ^{[1
]}

Tacito, Lucia H. ^{[1
]}

Forti, Adriana ^{[1
]}

Magalhaes, Maria E. ^{[1
]}

Chacra, Antonio R. ^{[1
]}

Bertolami, Marcelo C. ^{[1
]}

Loures-Vale, Andreia A. ^{[1
]}

Barros, Marco A. ^{[1
]}

Xavier, Hermes T. ^{[1
]}

Lyra, Ruy ^{[1
]}

Argamanijan, Dikran ^{[1
]}

Guimaraes, Armenio ^{[1
]}

Novazzi, Jose P. ^{[1
]}

Kasinski, Nelson ^{[1
]}

Afiune, Abrahao ^{[1
]}

Martinez, Tania L. ^{[1
]}

Santos, Raul D. ^{[1
]}

Nicolau, Jose C. ^{[1
]}

Cesar, Luiz A. ^{[1
]}

Povoa, Rui M. ^{[1
]}

Carvalho, Antonio C. ^{[1
]}

Han, Sang W. ^{[1
]}

Fonseca, Francisco A. ^{[1
]}

机构：

[1] Dept Med, Div Cardiol, Lipids Atherosclerosis & Vasc Biol Sect, BR-04039030 Sao Paulo, Brazil

来源：

ATHEROSCLEROSIS | 2009年 / 204卷 / 01期

关键词：

Diabetes; Myocardial infarction; Polymorphisms; Genetics; Lipids; Apolipoproteins; Lipoprotein lipase; CORONARY-HEART-DISEASE; MOLECULAR ANALYSIS; ARTERY-DISEASE; RISK; APOLIPOPROTEIN; PLASMA; CHOLESTEROL; METAANALYSIS; PROGRESSION; DEFICIENCY;

D O I：

10.1016/j.atherosclerosis.2008.08.006

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The association of polymorphisms affecting lipid metabolism with the risk of myocardial infarction (MI) in type 2 diabetes mellitus was investigated. The Genetics, Outcomes and Lipids in type 2 Diabetes (GOLD) Study is a prospective, multicenter study, conducted on 990 patients presenting diabetes and MI (n = 386). or diabetes without previous manifestation of stroke, peripheral or coronary arterial disease (n = 604), recruited from 27 institutions in Brazil. APO A1 (A/G -75 and C/T +83) and APO C3 (C/G 3'UTR) noncoding sequences, CETP (Taq 1B), LPL (D9N), APO E (epsilon 2, epsilon 3, epsilon 4,), PON-1 (Q192R), and two LCAT variants Arg(147) -> Trp and Tyr(171) -> Stop were tested by PCR-RFLP. There was a higher prevalence of LPL DN genotype (19% vs. 12%, p = 0.03) and a higher frequency of the N allele (11% vs. 7%) among subjects with MI when compared to controls, with an odds ratio of MI for carriers of 9N allele of 2.46 (95% CI = 1.79-3.39, p < 0.0001). This association was present in men and women, in non-smokers and in hypertensive patients. A logistic regression model including gender, duration of diabetes, systolic blood pressure, HDL-C, left ventricle hypertrophy and D9N polymorphism showed that the latter still remained significantly associated with MI (OR = 1.50,95% CI = 1.02-2.25, p = 0.049). These findings suggest that D9N polymorphism can be a useful risk marker for myocardial infarction and that further potential candidate genes should be screened for exploratory analysis and for future therapeutic intervention in diabetes. (C) 2008 Elsevier Ireland Ltd. All rights reserved.

引用

页码：165 / 170

页数：6

共 29 条

[1]

ADKINS S, 1993, AM J HUM GENET, V52, P598

[2] Type 2 diabetes in the young: The evolving epidemic - The International Diabetes Federation Consensus Workshop [J].

Alberti, G ;

Zimmet, P ;

Shaw, J ;

Bloomgarden, Z ;

Kaufman, F ;

Silink, M .

DIABETES CARE, 2004, 27 (07) :1798-1811

[3]

[Anonymous], 1993, DIABETES CARE, V16, P828

[4] Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women [J].

Bansal, Sandeep ;

Buring, Julie E. ;

Rifai, Nader ;

Mora, Samia ;

Sacks, Frank M. ;

Ridker, Paul M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (03) :309-316

[5] Abdominal obesity and dyslipidemia in the metabolic syndrome: Importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk [J].

Carr, MC ;

Brunzell, JD .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2601-2607

[6] Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population [J].

Corella, D ;

Sáiz, C ;

Guillén, M ;

Portolés, O ;

Mulet, F ;

González, JI ;

Ordovás, JM .

ATHEROSCLEROSIS, 2000, 152 (02) :367-376

[7] The use of meta-analysis risk estimates for candidate genes in combination to predict coronary heart disease risk [J].

Drenos, F. ;

Whittaker, J. C. ;

Humphries, S. E. .

ANNALS OF HUMAN GENETICS, 2007, 71 :611-619

[8] Enhanced bridging function and augmented monocyte adhesion by lipoprotein lipase N9: insights into increased risk of coronary artery disease in N9 carriers [J].

Fisher, RM ;

Benhizia, F ;

Schreiber, R ;

Makoveichuk, E ;

Putt, W ;

Al-Haideri, M ;

Deckelbaum, RJ ;

Olivecrona, G ;

Humphries, SE ;

Talmud, PJ .

ATHEROSCLEROSIS, 2003, 166 (02) :243-251

[9]

FONSECA FAH, 2006, INT J ATHEROSCLER, V1, P227

[10]

FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499

← 1 2 3 →